Pharmaceutical composition for treating liver cirrhosis and application thereof

Abstract

A pharmaceutical composition for treating liver cirrhosis is provided; the pharmaceutical composition is composed of the pharmaceutical raw materials: vervain, adenophora stricta miq., liquorice, radix sanguisorbae, sanguis draxonis, polygonum cuspidatum, fructus ligustri lucidi, rhizoma corydalis, wild buckwheat, rhizoma imperatae, spica prunellae, akebia stem, radix gentianae macrophyllae, erythrina variegata, endothelium corneum gigeriae galli, dandelion, capillary artemisia, rhizoma ligustici wallichii, roughhaired holly, safflower, herba lysimachiae, rhizoma sparganii, buddleja asiatica, piper hancei, kadsura pepper stem, barbed skullcap herb, pseudo-ginseng, spreading hedyotis herb, rhizoma gastrodiae, phyllanthus urinaria, agastache rugosus, gynostemma pentaphylla, fructus liquidambaris and cassia twig. The drug components in the combination are cooperative with each other, together play effects of clearing away heat and detoxifying, soothing liver and regulating circulation of qi, and promoting blood circulation to remove blood stasis, and have obvious effects in use for improving the living quality of patients with liver cirrhosis.

Description

technical field [0001] The invention belongs to the technical field of medicine and relates to a traditional Chinese medicine composition, in particular to a medicinal composition for treating liver cirrhosis and its application. Background technique [0002] Liver cirrhosis (hepatic cirrhosis) is a common clinical chronic progressive liver disease, which is diffuse liver damage caused by long-term or repeated effects of one or more etiologies. In my country, most of them are post-hepatitis cirrhosis, and a small part are alcoholic cirrhosis and schistosome cirrhosis. Histopathologically, extensive liver cell necrosis, nodular regeneration of residual liver cells, connective tissue hyperplasia, and fibrous septum formation lead to structural destruction of hepatic lobules and formation of pseudolobules. The liver gradually deforms and hardens and develops into cirrhosis. In the early stage, there are no obvious symptoms due to the strong compensatory function of the liver. ...

AI Technical Summary

Problems solved by technology

[0007] 2. Decompensation period (generally belongs to Child-Pugh B, C grade)

It can be seen that although the above conventional prescriptions for the treatment of chronic liver diseases can widely treat common chronic liver diseases, for the treatment of liver cirrhosis, there are problems of slow onset of effect and poor pertinence